JP Morgan Chase
AXDX

JP Morgan Chase’s Accelerate Diagnostics AXDX Stock Holding History

JP Morgan Chase’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-32
Closed -$23 – 7065
2025
Q1 		$23 Buy
32
+1
+3% +$1 ﹤0.01% 7097
2024
Q4 		$37 Sell
31
-2
-6% -$3 ﹤0.01% 7182
2024
Q3 		$57 Buy
33
+3
+10% +$4 ﹤0.01% 7093
2024
Q2 		$35 Buy
30
+15
+100% +$16 ﹤0.01% 7086
2024
Q1 		$15 Buy
15
+4
+36% +$6 ﹤0.01% 7198
2023
Q4 		$43 Buy
11
+3
+38% +$16 ﹤0.01% 7224
2023
Q3 		$46 Buy
8
+6
+300% +$40 ﹤0.01% 7010
2023
Q2 		$14 Hold
2
– – ﹤0.01% 6800
2023
Q1 		$0 Sell
2
-145,745
-100% -$876K ﹤0.01% 6683
2022
Q4 		$1.03M Buy
145,747
+885
+0.6% +$9.66K ﹤0.01% 4013
2022
Q3 		$2.2M Buy
144,862
+106,928
+282% +$1.77M ﹤0.01% 3390
2022
Q2 		$377K Sell
37,934
-3,902
-9% -$34.5K ﹤0.01% 4730
2022
Q1 		$602K Buy
41,836
+6,351
+18% +$181K ﹤0.01% 4586
2021
Q4 		$1.85M Buy
35,485
+34,175
+2,609% +$1.9M ﹤0.01% 3920
2021
Q3 		$76K Buy
1,310
+32
+3% +$2.09K ﹤0.01% 5698
2021
Q2 		$103K Sell
1,278
-676
-35% -$53.7K ﹤0.01% 5534
2021
Q1 		$162K Buy
1,954
+536
+38% +$54.4K ﹤0.01% 5227
2020
Q4 		$108K Buy
1,418
+259
+22% +$23.2K ﹤0.01% 4983
2020
Q3 		$125K Buy
1,159
+133
+13% +$18.5K ﹤0.01% 4590
2020
Q2 		$156K Buy
1,026
+131
+15% +$12.9K ﹤0.01% 4381
2020
Q1 		$75K Buy
895
+1
+0.1% +$141 ﹤0.01% 4604
2019
Q4 		$151K Hold
894
– – ﹤0.01% 4779
2019
Q3 		$166K Buy
894
+145
+19% +$28K ﹤0.01% 4710
2019
Q2 		$167K Buy
749
+113
+18% +$22.1K ﹤0.01% 4729
2019
Q1 		$134K Sell
636
-1,918
-75% -$360K ﹤0.01% 4783
2018
Q4 		$294K Buy
2,554
+1,950
+323% +$289K ﹤0.01% 4406
2018
Q3 		$139K Sell
604
-3,184
-84% -$704K ﹤0.01% 4827
2018
Q2 		$845K Buy
3,788
+3,257
+613% +$729K ﹤0.01% 3924
2018
Q1 		$121K Sell
531
-1,355
-72% -$356K ﹤0.01% 4531
2017
Q4 		$494K Buy
+1,886
New +$442K ﹤0.01% 4066
2017
Q2 		– Sell
-1,279
Closed -$309K – 4949
2017
Q1 		$309K Buy
1,279
+379
+42% +$86.6K ﹤0.01% 3899
2016
Q4 		$187K Sell
900
-6,672
-88% -$1.58M ﹤0.01% 4208
2016
Q3 		$2.06M Buy
7,572
+5,905
+354% +$1.31M ﹤0.01% 2786
2016
Q2 		$240K Buy
1,667
+1,660
+23,714% +$223K ﹤0.01% 3663
2016
Q1 		$1K Hold
7
– – ﹤0.01% 4552
2015
Q4 		$2K Buy
+7
New +$1.28K ﹤0.01% 4510

Other funds holding AXDX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

JP Morgan Chase's AXDX Position: Q2 2025 in Review

JP Morgan Chase sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 32 shares — an estimated $23 sold.

JP Morgan Chase first reported a position in AXDX in Q4 2015 and held it in 36 quarters. The position peaked at $2.2M in Q3 2022. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.

  • JP Morgan Chase reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 32 Accelerate Diagnostics shares in Q2 2025, an estimated $23.
  • JP Morgan Chase first reported a position in Accelerate Diagnostics in Q4 2015 and held it in 36 quarters.
  • JP Morgan Chase's Accelerate Diagnostics position peaked at $2.2M in Q3 2022.
  • 3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.